Synthetic Biology Market Size, Share Growth,Trends and Forecast| MarketsandMarkets™

1. Synthetic Biology Market Size, Share Growth,Trends and Forecast| MarketsandMarkets™ According to the new market research report "Synthetic Biology Market by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022", published by MarketsandMarkets™, The global synthetic biology market is expected to grow from USD 3.57 billion in 2017 to USD 8.84 billion by 2022, at a CAGR of 19.9% from 2017 to 2022. Don’t miss out on business opportunities in Synthetic Biology Market Synthetic biology has an array of applications in the fields of medicine, agriculture, nanotechnology, and industrial biotechnology. This has attracted interests of researchers from across the globe and has led to a rise in funding from public and private organizations, which, in turn, help in the growth of the market. Additionally, the reduction in costs per raw megabase of DNA sequencing and a drastic reduction in the cost of synthetic genes is expected to propel the market growth of synthetic biology. The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022. Wide range of applications of synthetic biology drives the global synthetic biology market The field of medicine has been in the forefront in terms of developing and applying synthetic biology techniques for various applications. Advancements in DNA sequencing and synthesizing technologies have resulted in the better understanding of diseases, aiding the research and discovery of biopharmaceuticals, small molecules, regenerative medicine, and antibody research.

2. Browse and in-depth TOC on "Synthetic Biology Market" 121 - Tables 32 - Figures 214 - Pages Get Free 10% customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=889 The synthetic biology market comprises a network of players involved in the research and product development; raw material supply; component manufacturing; distribution and sale; and post-sales services. Key players considered in the analysis of the global market are Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), Amyris (US), GenScript (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US). To know about the assumptions considered for the study, download the pdf brochure Major Market Developments: In 2017, Thermo Fisher (US) collaborated with AstraZeneca (US) and offered its CRISPR technology to AstraZeneca’s entire drug discovery platform. In 2017, Ginkgo Bioworks (US) acquired Gen9 (US), a Cambridge based gene synthesis company. In 2017, Intrexon (US) collaborated with Johnson Matthey (UK) to develop microbial strains for fermentative production of peptide-based active pharmaceutical ingredients (APIs) To speak to our analyst for a discussion on the above findings, click Speak to Analyst